Xiaming Jiang

机构：Chinese Academy of Sciences, Wuhan Institute of Virology · ORCID：0000-0002-6610-5484

发表论文 18 篇 · 总被引 951 次 · h-index 11

代表论文

• Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension (2020 · Cell Discovery · 被引 306)
• Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (2020 · Protein & Cell · 被引 210)
• Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome (2021 · Signal Transduction and Targeted Therapy · 被引 95)
• Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients (2021 · Signal Transduction and Targeted Therapy · 被引 75)
• Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro (2020 · Antiviral Research · 被引 63)
• Novel and potent inhibitors targeting DHODH, a rate-limiting enzyme in de novo pyrimidine biosynthesis, are broad-spectrum antiviral against RNA viruses including newly emerged coronavirus SARS-CoV-2 (2020 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 39)